PSC-04

N/A

Report date: 2024/11/24 20:00:04

Base Information

Drug NamePSC-04
Drug Alias NameCOVI-MSCPSC-04PSC04STI-8282STI8282 +[6] 
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesBrazil
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPersonalized Stem Cells Inc
China Registration ClassN/A

Develop Information

Active CompaniesPersonalized Stem Cells Inc
Inactive CompaniesSorrento Therapeutics Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A